ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,190, issued on Oct. 20, was assigned to ENTEROME S.A. (Paris).
"Antigenic peptides for prevention and treatment of cancer" was invented by Laurent Chene (Neuville aux Bois, France), Christophe Bonny (Paris) and Francesco Strozzi (Paris).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antigen-based immunotherapy, in particular cancer immunotherapy. In particular, the present invention provides antigenic peptides, which are distinct from, but have amino acid similarity to, fragments of human tumor antigens. The present invention further provides immunogenic compounds, nanoparticles, cells and pharmaceutical compositions ...